Intestinal Pathophysiological and Microbial Changes in Sickle Cell Disease: Potential Targets for Therapeutic Intervention

Authors

Dibyendu Dutta
Amandeep Aujla
Bettina M. Knoll, New York Medical CollegeFollow
Seah H. Lim, New York Medical CollegeFollow

Journal Title

British Journal of Haematology

First Page

488

Last Page

493

Document Type

Review Article

Publication Date

2-2020

Department

Medicine

Abstract

There is a large therapeutic gap in the treatment of sickle cell disease (SCD). Recent studies demonstrated the presence of pathophysiological and microbial changes in the intestine of patients with SCD. The intestinal microbes have also been found to regulate neutrophil ageing and possible basal activation of circulating neutrophils. Both aged and activated neutrophils are pivotal for the pathogenesis of vaso-occlusive crisis in SCD. In this paper, we will provide an overview of the intestinal pathophysiological and microbial changes in SCD. Based on these changes, we will propose therapeutic approaches that could be investigated for treating SCD.

Recommended Citation

Dutta, D., Aujla, A., Knoll, B. M., & Lim, S. H. (2020). Intestinal Pathophysiological and Microbial Changes in Sickle Cell Disease: Potential Targets for Therapeutic Intervention. British Journal of Haematology, 188 (4), 488-493. https://doi.org/10.1111/bjh.16273